DOI QR코드

DOI QR Code

Outcomes of Sleeve Lobectomy versus Pneumonectomy for Lung Cancer

  • Lee, Hong-Kyu (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Lee, Hee-Sung (Department of Thoracic and Cardiovascular Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Kun-Il (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Shin, Ho-Seung (Department of Thoracic and Cardiovascular Surgery, Hangang Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Lee, Jae-Woong (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Hyoung-Soo (Department of Thoracic and Cardiovascular Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Cho, Sung-Woo (Department of Thoracic and Cardiovascular Surgery, Kangdong Sacred Heart Hospital, Hallym University College of Medicine)
  • Received : 2011.07.11
  • Accepted : 2011.10.22
  • Published : 2011.12.05

Abstract

Background: Sleeve lobectomy for lung cancer in close proximity to or involving the carina is widely accepted. Operative morbidity and mortality rates, recurrence, and survival rates have varied considerably across studies. Materials and Methods: From March of 2005 to July of 2010, sleeve lobectomy was performed in 19 patients and pneumonectomy was performed in 20 patients. In this paper, the results of sleeve lobectomy and pneumonectomy for patients with lung cancer will be compared and evaluated. Results: There were no postoperative complications in either group, but there was one mortality in the pneumonectomy group. There was better preservation of pulmonary function in the sleeve lobectomy group than the pneumonectomy group (p=0.066 in FVC, p=0.019 in FEV1). The 3-year survival rates were 46.7% in the sleeve lobectomy group and 54.5% in the pneumonectomy group (p=0.505). The 3-year disease-free survival rates were 38% in the sleeve lobectomy group and 45.8% in the pneumonectomy group (p=0.200). Conclusion: Sleeve lobectomy for lung cancer showed low mortality, low bronchial anastomotic complication rates, and good preservation of pulmonary function.

Keywords

References

  1. Wain JC. Bronchoplastic resections. Philadelphia: Lippincott- Raven. 1998.
  2. Thomas CP. Conservative resection of the bronchial tree. J R Coll Surg Edinb 1956;1:169-86.
  3. Tedder M, Anstadt MP, Tedder SD, Lowe JE. Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy. Ann Thorac Surg 1992;54:387-91. https://doi.org/10.1016/0003-4975(92)91413-4
  4. Suen HC, Meyers BF, Guthrie T, et al. Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies. Ann Thorac Surg 1999;67:1557-62. https://doi.org/10.1016/S0003-4975(99)00372-0
  5. Faber LP. Sleeve lobectomy. Chest Surg Clin N Am 1995;5: 233-51.
  6. Gaissert HA, Mathisen DJ, Moncure AC, Hilgenberg AD, Grillo HC, Wain JC. Survival and function after sleeve lobectomy for lung cancer. J Thorac Cardiovasc Surg 1996; 111:948-53. https://doi.org/10.1016/S0022-5223(96)70369-0
  7. Weisel RD, Cooper JD, Delarue NC, Theman TE, Todd TR, Pearson FG. Sleeve lobectomy for carcinoma of the lung. J Thorac Cardiovasc Surg 1979;78:839-49.
  8. Van Schil PE, Brutel de la Rivière A, Knaepen PJ, van Swieten HA, Defauw JJ, van den Bosch JM. TNM staging and long-term follow-up after sleeve resection for bronchogenic tumors. Ann Thorac Surg 1991;52:1096-101. https://doi.org/10.1016/0003-4975(91)91287-6
  9. Tsubota N, Yoshimura M, Murotani A, Miyamoto Y, Matoba Y. One hundred and one cases of bronchoplasty for primary lung cancer. Surg Today 1994;24:978-81. https://doi.org/10.1007/BF02215810
  10. Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg 1998;115:836-40. https://doi.org/10.1016/S0022-5223(98)70364-2
  11. Van Schil PE, Brutel de la Rivière A, Knaepen PJ, van Swieten HA, Defauw JJ, van den Bosch JM. Second primary lung cancer after bronchial sleeve resection. Treatment and results in eleven patients. J Thorac Cardiovasc Surg 1992; 104:1451-5.
  12. Faber LP, Jensik RJ, Kittle CF. Results of sleeve lobectomy for bronchogenic carcinoma in 101 patients. Ann Thorac Surg 1984;37:279-85. https://doi.org/10.1016/S0003-4975(10)60729-1
  13. Okada M, Yamagishi H, Satake S, et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 2000;119:814-9. https://doi.org/10.1016/S0022-5223(00)70018-3
  14. Van Schil PE. Survival analysis after bronchoplastic resection. Eur J Cardiothorac Surg 1999;16:395-6. https://doi.org/10.1016/S1010-7940(99)00227-4
  15. Ferguson MK, Karrison T. Does pneumonectomy for lung cancer adversely influence long-term survival? J Thorac Cardiovasc Surg 2000;119:440-8. https://doi.org/10.1016/S0022-5223(00)70121-8
  16. Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983;86:654-8.
  17. Paul A, Marelli D, Shennib H, et al. Mucociliary function in autotransplanted, allotransplanted and sleeve resected lungs. J Thorac Cardiovasc Surg 1989;98:523-8.
  18. Deslauriers J, Gaulin P, Beaulieu M, Piraux M, Bernier R, Cormier Y. Long-term clinical and functional results of sleeve lobectomy for primary lung cancer. J Thorac Cardiovasc Surg 1986;92:871-9.
  19. Paulson DL, Urschel HC Jr, McNamara JJ, Shaw RR. Bronchoplastic procedures for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1970;59:38-48.
  20. Tronc F, Grégoire J, Rouleau J, Deslauriers J. Long-term results of sleeve lobectomy for lung cancer. Eur J Cardiothorac Surg 2000;17:550-6. https://doi.org/10.1016/S1010-7940(00)00405-X

Cited by

  1. Bronchusmanschettenresektion : Perioperatives Risiko und funktionelles Ergebnis vol.84, pp.6, 2013, https://doi.org/10.1007/s00104-012-2429-0